Analysis of Meaningful Conditioned Pain Modulation Effect in a Pain-Free Adult Population

被引:64
作者
Locke, David [1 ]
Gibson, William [1 ,2 ]
Moss, Penny [1 ]
Munyard, Kylie [3 ,4 ]
Mamotte, Cyril [3 ,4 ]
Wright, Anthony [1 ]
机构
[1] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA 6845, Australia
[2] Univ Notre Dame Australia, Sch Physiotherapy, Fremantle, WA, Australia
[3] Curtin Univ, Sch Biomed Sci, Perth, WA 6845, Australia
[4] Curtin Univ, CHIRI Biosci Res Precinct, Perth, WA 6845, Australia
关键词
Conditioned pain modulation; diffuse noxious inhibitory controls; serotonin transporter gene; gender; healthy adults; NOXIOUS INHIBITORY CONTROLS; SEX-DIFFERENCES; ENDOGENOUS ANALGESIA; TEMPORAL SUMMATION; GENDER-DIFFERENCES; MUSCLE PAIN; HUMANS; ASSOCIATION; SENSITIVITY; MAGNITUDE;
D O I
10.1016/j.jpain.2014.09.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Conditioned pain modulation (CPM) encompasses the effects of inhibitory and facilitatory pain modulatory systems and is inefficient in some chronic pain states. A proportion of healthy subjects also exhibit little or no CPM, perhaps suggesting that inherent factors such as gender or genetics may be influential. However, there is no consensus on how best to determine a meaningful (PM effect. This study aimed to determine the proportion of pain-free subjects exhibiting a meaningful CPM effect. Analyses of associations between 5HTTLPR (serotonin transporter-linked polymorphic region) polymorphisms on the serotonin transporter gene (SLC6A4), gender, and CPM effect were also carried out. A total of 125 healthy subjects (47 male; 78 female) underwent pressure pain threshold testing before, during, and after a cold pressor conditioning stimulus. A buccal cell sample was collected for analysis of 5HTTLPR genotype. Meaningful CPM effect was determined as an increase in pressure pain threshold values from baseline greater than the inherent error of measurement, calculated as 5.3%. During the conditioning stimulus, 116 subjects (92.8%) exhibited a CPM effect whereas 9 did not. CPM effect did not differ significantly between genders or between 5HTTLPR genotypes. This provides a clear basis on which to determine the proportion of patients with a chronic pain disorder that exhibit a meaningful CPM effect. Perspective: This study proposes a method for calculating meaningful CPM effect and reports the proportion and magnitude of effect elicited in a large sample. Associations between CPM, gender, and genotype were also analyzed. Clarification of normal CPM response may help to elucidate the mechanisms driving CPM inefficiency in chronic pain. Crown Copyright (C) 2014 Published by Elsevier Inc. on behalf of the American Pain Society
引用
收藏
页码:1190 / 1198
页数:9
相关论文
共 42 条
[1]   Sensitization in patients with painful knee osteoarthritis [J].
Arendt-Nielsen, Lars ;
Nie, Hongling ;
Laursen, Mogens B. ;
Laursen, Birgitte S. ;
Madeleine, Pascal ;
Simonsen, Ole H. ;
Graven-Nielsen, Thomas .
PAIN, 2010, 149 (03) :573-581
[2]   Experimental muscle pain impairs descending inhibition [J].
Arendt-Nielsen, Lars ;
Sluka, Kathleen A. ;
Nie, Hong Ling .
PAIN, 2008, 140 (03) :465-471
[3]   Lack of sex differences in modulation of experimental intraoral pain by diffuse noxious inhibitory controls (DNIC) [J].
Baad-Hansen, L ;
Poulsen, HF ;
Jensen, HM ;
Svensson, P .
PAIN, 2005, 116 (03) :359-365
[4]   Ethnic differences in diffuse noxious inhibitory controls [J].
Campbell, Claudia M. ;
France, Christopher R. ;
Robinson, Michael E. ;
Logan, Henrietta L. ;
Geffken, Gary R. ;
Fillingim, Roger B. .
JOURNAL OF PAIN, 2008, 9 (08) :759-766
[5]   Gender Differences in Pain Severity, Disability, Depression, and Widespread Pressure Pain Sensitivity in Patients with Fibromyalgia Syndrome Without Comorbid Conditions [J].
Castro-Sanchez, Adelaida M. ;
Mataran-Penarrocha, Guillermo A. ;
Lopez-Rodriguez, Maria M. ;
Lara-Palomo, Inmaculada C. ;
Arendt-Nielsen, Lars ;
Fernandez-de-las-Penas, Cesar .
PAIN MEDICINE, 2012, 13 (12) :1639-1647
[6]   Gender differences in pressure pain threshold in healthy humans [J].
Chesterton, LS ;
Barlasb, P ;
Foster, NE ;
Baxter, GD ;
Wright, CC .
PAIN, 2003, 101 (03) :259-266
[7]  
Duan Guang-You, 2012, Zhonghua Yi Xue Za Zhi, V92, P448, DOI 10.3760/cma.j.issn.00376-2491-2012.07.005
[8]   Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations [J].
Dworkin, Robert H. ;
Turk, Dennis C. ;
Wyrwich, Kathleen W. ;
Beaton, Dorcas ;
Cleeland, Charles S. ;
Farrar, John T. ;
Haythornthwaite, Jennifer A. ;
Jensen, Mark P. ;
Kerns, Robert D. ;
Ader, Deborah N. ;
Brandenburg, Nancy ;
Burke, Laurie B. ;
Cella, David ;
Chandler, Julie ;
Cowan, Penny ;
Dimitrova, Rozalina ;
Dionne, Raymond ;
Hertz, Sharon ;
Jadad, Alejandro R. ;
Katz, Nathaniel P. ;
Kehlet, Henrik ;
Kramer, Lynn D. ;
Manning, Donald C. ;
McCormick, Cynthia ;
McDermott, Michael P. ;
McQuay, Henry J. ;
Patel, Sanjay ;
Porter, Linda ;
Quessy, Steve ;
Rappaport, Bob A. ;
Rauschkolb, Christine ;
Revickl, Dennis A. ;
Rothman, Margaret ;
Schmader, Kenneth E. ;
Stacey, Brett R. ;
Stauffer, Joseph W. ;
Von Stein, Thorsten ;
White, Richard E. ;
Witter, James ;
Zavislc, Stojan .
JOURNAL OF PAIN, 2008, 9 (02) :105-121
[9]   Individual differences in diffuse noxious inhibitory controls (DNIC): association with clinical variables [J].
Edwards, RR ;
Ness, TJ ;
Weigent, DA ;
Fillingim, RB .
PAIN, 2003, 106 (03) :427-437
[10]   The A118G single nucleotide polymorphism of the μ-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans [J].
Fillingim, RB ;
Kaplan, L ;
Staud, R ;
Ness, TJ ;
Glover, TL ;
Campbell, CM ;
Mogil, JS ;
Wallace, MR .
JOURNAL OF PAIN, 2005, 6 (03) :159-167